1. |
Song B, Cui H, Li Y, et al. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China. Oncotarget, 2016, 7(3): 3599-3613.
|
2. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
|
3. |
Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med, 2014, 371(26): 2499-2509.
|
4. |
Kelty CJ, Kennedy CW, Falk GL. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol, 2010, 5(9): 1467-1471.
|
5. |
Liu Q, Cai XW, Wu B, et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy. PLoS One, 2014, 9(5): e97225.
|
6. |
Ma GW, Situ DR, Ma QL, et al. Three-field vs. two-field lymph node dissection for esophageal cancer: a meta-analysis. World J Gastroenterol, 2014, 20(47): 18022-18030.
|
7. |
Tan Z, Ma G, Zhao J, et al. Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg, 2014, 18(1): 187-193.
|
8. |
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004, 240(2): 205-213.
|
9. |
Wang F, Zheng Y, Wang Z, et al. Nodal skip metastasis in esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Thorac Surg, 2017, 104(4): 1187-1193.
|
10. |
Motoyama S, Mori K, Kamei T, et al. Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma. Ann Surg Oncol, 2013, 20(6): 1978-1984.
|
11. |
Akutsu Y, Matsubara H. Lymph node dissection for esophageal cancer. Gen Thorac Cardiovasc Surg, 2013, 61(7): 397-401.
|
12. |
吴灿兴, 张树亮, 陈椿. 胸段食管鳞癌患者的喉返神经旁淋巴结转移特点. 中华胸部外科电子杂志, 2016, 3(1): 21-24.
|
13. |
Shi Y, Xu J, Wang Y, et al. Prognostic significance of preoperative lymph node assessment for patients with stage pN0 esophageal squamous cell carcinoma after esophagectomy. J Thorac Dis, 2019, 11(3): 732-743.
|
14. |
Perry Y, Fernando HC. Three-field minimally invasive esophagectomy: current results and technique. Thorac Cardiovasc Surg, 2012, 144(3): S63-S66.
|
15. |
Ding X, Zhang J, Li B, et al. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol, 2012, 85(1019): e1110-e1119.
|
16. |
Yang HX, Xu Y, Fu JH, et al. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China. Ann Surg Oncol, 2010, 17(7): 1901-1911.
|
17. |
Dutkowski P, Hommel G, Böttger T, et al. How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value. Hepatogastroenterology, 2002, 49(43): 176-180.
|
18. |
叶鑫, 赵彦, 游宾, 等. 《食管癌根治术胸部淋巴结清扫中国专家共识(2017 版)》解读. 中华胃肠外科杂志, 2018, 21(9): 976-982.
|
19. |
王镇, 柳硕岩. 食管胸中段鳞状细胞癌喉返神经旁淋巴结清扫的临床价值. 中华胃肠外科杂志, 2015, 18(9): 867-870.
|
20. |
Saito Y, Takeuchi H, Fukuda K, et al. Size of recurrent laryngeal nerve as a new risk factor for postoperative vocal cord paralysis. Dis Esophagus, 2018, 31(6).
|
21. |
Wani S, Drahos J, Cook MB, et al. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc, 2014, 79(2): 224-232.
|
22. |
McLaren PJ, Dolan JP. Esophagectomy as a treatment consideration for early-stage esophageal cancer and high-grade dysplasia. J Laparoendosc Adv Surg Tech A, 2016, 26(10): 757-762.
|
23. |
Koyanagi K, Igaki H, Iwabu J, et al. Recurrent laryngeal nerve paralysis after esophagectomy: respiratory complications and role of nerve reconstruction. Tohoku J Exp Med, 2015, 237(1): 1-8.
|